Pink Light on Mitochondria in Autoimmunity and Parkinson Disease

Adriana R Mantegazza1, Michael S Marks1

  • 1Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Cell Metabolism
|July 14, 2016
PubMed

Insights

Mitochondrial dysfunction and T cell autoimmunity are linked in Parkinson disease. Familial Parkinson disease activates a mechanism where mitochondrial proteins are processed for CD8+ T cell recognition.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Mitochondrial dysfunction is implicated in Parkinson disease (PD) pathogenesis.
  • T cell autoimmunity is also independently linked to Parkinson disease.
  • A gap exists in understanding the interplay between these factors in PD.

Purpose of the Study:

  • To investigate a potential link between mitochondrial dysfunction and T cell activation in Parkinson disease.
  • To elucidate a mechanism connecting mitochondrial protein processing to T cell recognition in familial PD.

Main Methods:

  • Analysis of cellular mechanisms in familial Parkinson disease models.
  • Investigating the processing of mitochondrial proteins.
  • Assessing the recognition of processed mitochondrial proteins by CD8+ T cells.

Main Results:

  • A novel mechanism activated in familial Parkinson disease was described.
  • This mechanism involves the processing of mitochondrial proteins.
  • These processed proteins are recognized by CD8+ T cells, suggesting a link to autoimmunity.

Conclusions:

  • Mitochondrial protein processing and T cell autoimmunity are mechanistically linked in familial Parkinson disease.
  • This finding provides a new perspective on Parkinson disease pathogenesis.
  • The described mechanism may represent a therapeutic target for Parkinson disease.